Primary Record
Daraxonrasib
- In stock
- 9,033 g
- Purity
- 99.5 %
- CAS
- 2765081-21-6
Compound Identifiers & Properties
- CAS
- 2765081-21-6
- PubChem CID
- 164726578
- SMILES
- CCN1C2=C3C=C(C=C2)C4=CSC(=N4)C[C@@H](C(=O)N5CCC[C@H](N5)C(=O)OCC(CC3=C1C6=C(N=CC(=C6)N7CCN(CC7)C)[C@H](C)OC)(C)C)NC(=O)[C@H]8C[C@@H]8C
- Canonical SMILES
- CCn1c(-c2cc(N3CCN(C)CC3)cnc2[C@H](C)OC)c2c3cc(ccc31)-c1csc(n1)C[C@H](NC(=O)[C@H]1C[C@@H]1C)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2
Names & Synonyms
- Daraxonrasib
- RAS-IN-2
- RMC-6236
- daraxonrasib [INN]
- RAS Inhibitor A122
- A1AHB
- B6T47Y2UAP
- RefChem:1082975
- DARAXONRASIB [USAN]
- RMC6236
- SCHEMBL25774297
- SCHEMBL31152365
- EX-A6631B
- GTPL13368
- 2765081-21-6
- RMC 6236 [WHO-DD]
- GLXC-27997
- RMC 6236
- NSC852671
- AT43357
- NSC-852671
- RMC-0706236
- SY347092
- HY-148439
- CS-0626513
- A948815
- pyridazinacycloundecaphane-4-yl)-2-methylcyclopropane-1-carboxamide
- (1S,2S)-N-((63S,4S,Z)-11-Ethyl-12-(2-((S)-1-methoxyethyl)-5-(4-methylpiperazin-1-yl)pyridin-3-yl )-10,10-dimethyl-5,7-dioxo-61,62,63,64,65,66-hexahydro-11H-8-oxa-2(4,2)-thiazola-1(5,3)-indola -6(1,3)-
- (1S,2S)-N-[(12M,4S,63S)-11-ethyl-12-{2-[(1S)-1-methoxyethyl]-5-(4-methylpiperazin-1-yl)pyridin-3-yl}-10,10-dimethyl-5,7-dioxo-11H-8-oxa-1(5,3)-indola-6(1,3)-[1,2]diazinana-2(4,2)-[1,3]thiazolacycloundecaphan-4-yl]-2-methylcyclopropane-1-carboxamide
- (1S,2S)-N-[(2R,14S,18S)-1-Ethyl-18,19,20,21-tetrahydro-2-[2-[(1S)-1-methoxyethyl]-5-(4-methyl-1-piperazinyl)-3-pyridinyl]-25,25-dimethyl-15,22-dioxo-17H-5,3-([4,2]-endo-thiazolopropano[1,3]-endo-pyridazinomethanoxypropano)-1H-indol-14-yl]-2-methyl-cyclopropanecarboxamide
- Cyclopropanecarboxamide, N-[(2R,14S,18S)-1-ethyl-18,19,20,21-tetrahydro-2-[2-[(1S)-1-methoxyethyl]-5-(4-methyl-1-piperazinyl)-3-pyridinyl]-25,25-dimethyl-15,22-dioxo-17H-5,3-([4,2]-endo-thiazolopropano[1,3]-endo-pyridazinomethanoxypropano)-1H-indol-14-yl]-2-methyl-, (1S,2S)-